|
We asked 40 pharma professionals, What is the biggest threat to industry in the
next five years
| Lack of innovation |
59% |
| Poor pricing and uptake |
22% |
| Regulation |
16% |
| Generic competition |
3% |
 |
|
|
|
|
|
|
|
21 January, 2014
|
|
|
European Pharma Regulatory Outlook 2014
Pharm Exec’s Brussels correspondent Reflector looks at some of the mooted EU regulatory developments for 2014 and anticipates their effect on the pharma industry ...Read more |
Engage, But More Gently: More Thoughts on Industry Trends 2014
According to Ipsos Healthcare’s Elys Roberts, the industry’s all-important reputational scorecard is finally rebounding after years of declining confidence among a variety of stakeholders ... Read more
|
Pharma and Social Media: Have We Reached the Tipping Point?
The FDA released its draft guidance on the use of “Interactive Promotional Media” this month, ending several years of speculation and finally providing the industry with substantial guidance on its use of digital media ... Read more
|
US: Obamacare and the “New Medical Culture”
Tom Norton outlines the Obamacare-related questions likely to be on the lips of US pharma this year ... Read more
|
Drugs, At What Cost?
As government austerity programs, blockbuster drugs falling off the patent cliff, and varying medical and regulatory practices worldwide continue to shape the financial outlook of bio/pharmaceutical companies, the underlying question for any drug in development is: What price can (or will) patients pay for the needed therapy? ... Read more
|
|
| Sciformix |
 Scignal Plus: Taking the Noise Out of Signal Detection
Scignal Plus provides superior, efficient signal detection by incorporating computational algorithms for a new method and previously known methods of signal detection. It has several distinct and important advantages over other products that are available in the market.  Read more. |
|
|
|
|
|
|
|
|
